ARCHIVES

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

NCI Must Build a Research Community In Pancreatic Cancer, Review Groups Says.

March 9, 2001

Foundation For COG Is New Name Of NCCF.

October 19, 2001